Pure Bioscience's market cap is currently $10.01M. The company's EPS TTM is $-0.005; its P/E ratio is ―; Pure Bioscience is scheduled to report earnings on April 30, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
